Michael R. Hayden - Dec 7, 2021 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role: Director
Signature: /s/ Tryn Stimart, attorney in fact
Stock symbol: ABCL
Transactions as of: Dec 7, 2021
Transactions value $: $0
Form type: 4
Date filed: 12/10/2021, 12:13 PM
Previous filing: Oct 19, 2021
Next filing: Mar 30, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ABCL	Common Shares						1.27M	Dec 7, 2021	See footnote	F1
holding	ABCL	Common Shares						118K	Dec 7, 2021	By spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ABCL	Share option (right to buy)	Award	$0	+34.3K	+5.36%	$0.00	674K	Aug 27, 2021	Common Shares	34.3K	$17.58	Direct
transaction	ABCL	Share option (right to buy)	Award	$0	+45.5K	+11.26%	$0.00	450K	Dec 7, 2021	Common Shares	45.5K	$14.55	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held by Genworks 2 Consulting, Inc. ("Genworks 2"). The Reporting Person's spouse has sole voting and investment power with respect to the shares held by Genworks 2. The reporting person disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest, if any, therein.